Workflow
人民币贬值受益
icon
Search documents
上海港湾涨0.83%,成交额4.33亿元,近5日主力净流入-5736.91万
Xin Lang Cai Jing· 2025-12-17 08:11
1、2025年3月6日微信公众号发布,作为A股主板上市公司上海港湾基础建设(集团)股份有限公司下 属控股子公司,伏曦炘空依托集团雄厚的技术实力和积累,在商业航天能源领域走出了一条创新之路。 伏曦炘空专注于为客户提供轻、廉、高效的空间能源系统解决方案及产品研发服务。其技术团队汇聚了 航天院所、中科院及高校精英,均有着15年以上航天工程经验,确保伏曦炘空能够为卫星、探测器等空 间飞行器提供低成本高性能的能源系统。公司能源系统产品,已成功保障15颗卫星成功发射,所有产品 在轨工作正常。 2、根据2025年7月11日投资者关系活动记录表:公司旗下控股子公司上海伏曦炘空科技有限公司,聚焦 卫星、空间飞行器、无人机等领域的能源需求,专注于为客户提供轻量化、低成本、高性能的空间能源 系统解决方案,并深度参与关键产品研发服务。在技术落地与市场应用层面,该公司已取得显著成果: 其能源系统产品成功助力 15 颗卫星发射入轨,40 余套卫星电源系统、太阳帆板及结构机构持续在轨稳 定运行,充分验证了产品的可靠性与稳定性。2025年上半年,该公司卫星电源系统业务呈现快速增长态 势,订单储备丰盈且增速亮眼,已构建起"研发创新-工程验证– ...
海普瑞跌0.26%,成交额3126.21万元,后市是否有机会?
Xin Lang Cai Jing· 2025-12-17 07:29
Core Viewpoint - The company, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., is a leading multinational pharmaceutical enterprise with a focus on the heparin industry chain, biopharmaceutical CDMO, and innovative drug development, benefiting from the depreciation of the RMB and strong overseas revenue [2][3]. Company Overview - Established in 1998 and listed in 2010, Hepalink's main business includes the research, production, and sales of heparin sodium raw materials and downstream low molecular weight heparin products [7]. - The company's revenue composition is as follows: formulations 63.06%, CDMO 18.59%, heparin sodium and low molecular weight heparin raw materials 16.05%, and others 2.30% [7]. - As of September 30, 2025, Hepalink achieved a revenue of 4.194 billion yuan, a year-on-year increase of 3.09%, while the net profit attributable to shareholders decreased by 29.04% to 554 million yuan [7]. Financial Performance - The company's overseas revenue accounts for 93.04%, benefiting from the depreciation of the RMB [3]. - The total market capitalization is 17.079 billion yuan, with a trading volume of 31.2621 million yuan and a turnover rate of 0.22% [1]. - The company has distributed a total of 4.21 billion yuan in dividends since its A-share listing, with 514 million yuan distributed in the last three years [8]. Institutional Holdings - As of September 30, 2025, the eighth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 12.0093 million shares, an increase of 691,700 shares compared to the previous period [9]. Market Activity - The stock experienced a slight decline of 0.26% on December 17, with a net inflow of 429,600 yuan from major investors, representing 0.02% of the total [4][5].
赤峰黄金跌5.38%,成交额19.02亿元,今日主力净流入-6295.62万
Xin Lang Cai Jing· 2025-12-16 12:06
来源:新浪证券-红岸工作室 12月16日,赤峰黄金跌5.38%,成交额19.02亿元,换手率3.64%,总市值587.80亿元。 异动分析 金属铅+黄金概念+金属铜+人民币贬值受益+稀土永磁 1、根据2024年半年报,公司旗下天宝山锌铅铜钼多金属矿主要产品包括锌精粉、铅精粉(含银)、铜 精粉(含银)和钼精粉。其对外销售的定价一般以精矿中所含的金属的市场价格为基准确定。主要是以 上海有色网1#锌锭的价格、1#铅现货的价格,上海期货交易所铜即期合约结算价为基准价,并根据精粉 产品中实际金属含量,综合考虑运输费、检斤费等因素确定结算价格;产品销售主要是通过预收货款的 方式进行,产品销售对象为长期合作的下游大型冶炼企业。 2、公司的主营业务是黄金、有色金属采选业务。公司的主要产品为黄金、电解铜等贵金属、有色金 属。 3、公司位于老挝的万象矿业目前主要从事铜矿开采和冶炼。 4、根据2024年年报,公司海外营收占比为69.11%,受益于人民币贬值。 5、2024年3月8日互动易:公司与厦门钨业合作,共同在老挝推动稀土资源开发。近日通过控股子公司 收购的"老挝川圹省勐康稀土矿"项目,估算矿种为花岗岩风化壳离子吸附稀土矿,矿 ...
采纳股份跌3.28%,成交额7478.06万元,今日主力净流入55.69万
Xin Lang Cai Jing· 2025-12-16 09:30
来源:新浪证券-红岸工作室 12月16日,采纳股份跌3.28%,成交额7478.06万元,换手率3.46%,总市值34.19亿元。 区间今日近3日近5日近10日近20日主力净流入55.69万489.58万738.57万1493.98万1453.75万 主力持仓 主力没有控盘,筹码分布非常分散,主力成交额801.27万,占总成交额的2.39%。 异动分析 辅助生殖+医疗器械概念+人民币贬值受益 1、公司采纳医疗于2018年开始向Thermo Fisher 供应试管婴儿培育管产品。 2、公司主营业务为从事注射穿刺器械及实验室耗材的研发、生产和销售。公司目前主要产品为穿刺 针、注射器、实验室耗材及口罩等。 3、根据2024年年报,公司海外营收占比为90.61%,受益于人民币贬值。 (免责声明:分析内容来源于互联网,不构成投资建议,请投资者根据不同行情独立判断) 资金分析 今日主力净流入55.69万,占比0.01%,行业排名27/132,连续2日被主力资金增仓;所属行业主力净流 入-3.47亿,当前无连续增减仓现象,主力趋势不明显。 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包 ...
捷邦科技涨1.44%,成交额1.30亿元,近5日主力净流入2201.79万
Xin Lang Cai Jing· 2025-12-16 07:45
Core Viewpoint - The company, Jieban Technology, is experiencing growth in its liquid cooling server business and has significant reliance on major clients like Foxconn and Apple, while also benefiting from the depreciation of the Chinese yuan. Group 1: Company Performance - Jieban Technology's stock increased by 1.44% with a trading volume of 1.30 billion yuan and a market capitalization of 74.32 billion yuan [1] - The company reported a revenue of 962 million yuan for the first nine months of 2025, representing a year-on-year growth of 62.04%, but incurred a net loss of 12.58 million yuan, a decrease of 1762.51% compared to the previous year [7] - The company has distributed a total of 43.24 million yuan in dividends since its A-share listing [8] Group 2: Client and Revenue Dependency - The company's liquid cooling server business is progressing as planned, but specific project details are confidential due to non-disclosure agreements with clients [2] - Major clients include Foxconn, Quanta Computer, Compal Electronics, and BYD, with sales to Foxconn accounting for 35.58%, 36.85%, and 39.52% of revenue in recent periods [2] - A significant portion of the company's products is used in Apple laptops and tablets, with sales to Apple products making up 85.22%, 77.95%, and 81.27% of revenue [2] Group 3: Market and Financial Analysis - The company's overseas revenue accounted for 67.79% in the 2024 annual report, benefiting from the depreciation of the yuan [3] - The average trading cost of the stock is 111.67 yuan, with the stock price nearing a support level of 101.00 yuan [6] - The main capital inflow today was 6.79 million yuan, with a net inflow of 10.36 million yuan over the last three days [5]
联特科技跌8.81%,成交额23.10亿元,今日主力净流入-3.24亿
Xin Lang Cai Jing· 2025-12-16 07:45
来源:新浪证券-红岸工作室 12月16日,联特科技跌8.81%,成交额23.10亿元,换手率22.86%,总市值188.13亿元。 异动分析 共封装光学(CPO)+5G+芯片概念+数据中心+人民币贬值受益 1、2022年12月8日互动易回复:公司拥有了光芯片集成、高速光器件以及高速光模块设计、生产的核心 能力,在高速信号设计和仿真、光学仿真和光耦合工艺领域掌握了相关核心技术。公司目前研发的有基 于EML(电吸收调制激光器)、SIP(硅光)、TFLN(薄膜铌酸锂)调制技术的800G光模块,以及用 于下一代产品NPO(近封装光学)/CPO(共封装光学)所需的高速光连接技术、激光器技术和芯片级 光电混合封装技术等。 今日主力净流入-3.24亿,占比0.14%,行业排名79/88,该股当前无连续增减仓现象,主力趋势不明显; 所属行业主力净流入-71.01亿,连续2日被主力资金减仓。 区间今日近3日近5日近10日近20日主力净流入-3.24亿-1523.28万3536.48万8605.66万5.14亿 主力持仓 主力轻度控盘,筹码分布较为分散,主力成交额11.58亿,占总成交额的10.83%。 2、光模块目前主要应用市 ...
五洲医疗跌3.88%,成交额1.45亿元,后市是否有机会?
Xin Lang Cai Jing· 2025-12-16 07:45
Core Viewpoint - Wuzhou Medical experienced a decline of 3.88% in stock price on December 16, with a trading volume of 145 million yuan and a market capitalization of 2.965 billion yuan [1] Group 1: Company Overview - Wuzhou Medical specializes in the research, production, and sales of disposable sterile infusion medical devices, including various types of syringes, infusion sets, blood transfusion sets, and other related medical supplies [2][7] - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which signifies its strong market position and innovation capabilities [2] - As of October 20, the company reported a revenue of 345 million yuan for the period from January to September 2025, representing a year-on-year growth of 0.82%, while the net profit attributable to shareholders decreased by 46.09% to 18.51 million yuan [7] Group 2: Financial Performance - The company's overseas revenue accounted for 96.88% of total revenue, benefiting from the depreciation of the RMB [3] - The average trading cost of the stock is 42.62 yuan, with the current stock price near a support level of 43.15 yuan, indicating potential for a rebound if this support holds [6] - The company has distributed a total of 81.6 million yuan in dividends since its A-share listing [8] Group 3: Market Activity - On the trading day mentioned, the main net inflow of funds was 7.6572 million yuan, accounting for 0.05% of the total, with the industry ranking at 7 out of 132 [4] - The stock has seen a continuous increase in main funds over the past three days, although the overall trend remains unclear [5]
联域股份跌2.10%,成交额2690.50万元,近5日主力净流入-683.78万
Xin Lang Cai Jing· 2025-12-16 07:45
Core Viewpoint - The company, Shenzhen Lianyu Optoelectronics Co., Ltd., is actively expanding its business in smart lighting, charging piles, and energy storage, benefiting from the depreciation of the RMB and the Belt and Road Initiative. Group 1: Business Development - The company is advancing new technologies in smart lighting, including self-adaptive plant control spectrum and wireless networking for intelligent control circuits, with a focus on product intelligence and IoT integration [2] - The company has developed charging piles and energy storage solutions through its wholly-owned subsidiary, Shenzhen Haibo, which have already generated revenue [2][3] - The company has established production bases in Vietnam and Mexico to enhance its manufacturing capabilities [4] Group 2: Financial Performance - For the first nine months of 2025, the company achieved a revenue of 1.155 billion yuan, representing a year-on-year growth of 1.03%, while the net profit attributable to shareholders decreased by 79.23% to 19.5341 million yuan [8] - The company's overseas revenue accounted for 95.62% of total revenue, benefiting from the depreciation of the RMB [3] Group 3: Market Activity - On December 16, the company's stock price fell by 2.10%, with a trading volume of 26.905 million yuan and a turnover rate of 2.71%, bringing the total market capitalization to 3 billion yuan [1] - The main funds showed a net outflow of 570,600 yuan today, with a continuous reduction in the last three days [5][6] Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 20.62% to 6,765, while the average circulating shares per person increased by 25.97% to 3,562 shares [8]
三态股份跌0.25%,成交额5943.48万元,今日主力净流入336.40万
Xin Lang Cai Jing· 2025-12-16 07:45
Core Viewpoint - The company, Shenzhen SanTai E-commerce Co., Ltd., is focused on cross-border e-commerce retail and logistics, benefiting from the depreciation of the RMB and leveraging AI technologies for operational efficiency and risk management [2][3][7]. Group 1: Company Overview - Shenzhen SanTai E-commerce Co., Ltd. was established on January 7, 2008, and listed on September 28, 2023, with its main business involving cross-border e-commerce retail (76.14% of revenue) and logistics (23.80% of revenue) [7]. - The company has a total market capitalization of 6.342 billion yuan and a trading volume of 59.4348 million yuan on December 16, with a share price decline of 0.25% [1]. Group 2: Business Developments - The company is developing an AIGC project that utilizes Stable Diffusion for generating high-quality images, enhancing brand IP and operational efficiency [2]. - The company launched a proprietary intellectual property risk detection tool named "RuiGuan·ERiC" on September 28, 2023, aimed at providing low-cost and accurate risk monitoring solutions for enterprises [3]. Group 3: Financial Performance - For the period from January to September 2025, the company reported a revenue of 1.252 billion yuan, reflecting a year-on-year growth of 0.15%, while the net profit attributable to shareholders decreased by 25.94% to 31.8471 million yuan [8]. - The company's overseas revenue accounted for 99.98% of its total revenue, benefiting from the depreciation of the RMB [3]. Group 4: Market Position and Shareholder Information - As of December 10, 2023, the company had 28,500 shareholders, with an average of 7,708 circulating shares per person, showing a slight increase of 0.22% [8]. - The company has distributed a total of 110 million yuan in dividends since its A-share listing [9].
开创电气跌2.58%,成交额3900.38万元,今日主力净流入-41.05万
Xin Lang Cai Jing· 2025-12-16 07:45
Core Viewpoint - The company, Zhejiang Kaichuang Electric Co., Ltd., is experiencing fluctuations in stock performance and is focusing on expanding its lithium battery product line and e-commerce sales, while also benefiting from the depreciation of the RMB [2][6]. Group 1: Company Performance - On December 16, Kaichuang Electric's stock fell by 2.58%, with a trading volume of 39.0038 million yuan and a market capitalization of 6.088 billion yuan [1]. - For the period from January to September 2025, the company reported a revenue of 490 million yuan, a year-on-year decrease of 12.96%, and a net profit attributable to shareholders of -10.4633 million yuan, a year-on-year decrease of 119.10% [6]. - The company has distributed a total of 67.12 million yuan in dividends since its A-share listing [7]. Group 2: Market and Industry Analysis - The company has developed 20 new lithium battery products in 2023, gaining recognition from clients such as Bosch and Harbor Freight Tools, with lithium battery sales currently accounting for less than 10% of total revenue, indicating significant growth potential [2]. - The company's overseas revenue accounted for 91.85% of total revenue, benefiting from the depreciation of the RMB [2]. - Kaichuang Electric has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which enhances its competitiveness and stability within the industry [2]. - The company has been expanding its e-commerce business since 2018, with online sales revenue increasing by 58.64% year-on-year in 2024 [2]. Group 3: Technical Analysis - The average trading cost of the stock is 60.15 yuan, with the current stock price fluctuating between a resistance level of 60.34 yuan and a support level of 53.82 yuan, suggesting potential for range trading [5]. - The main capital inflow for the stock today was -410,500 yuan, with a net inflow of -7.4172 million yuan over the last three days, indicating a trend of capital reduction [4].